I agree that this site is using cookies. You can find further informations here.
X
Baker-Knight, James
1593  results:
Search for persons X
?
1

Assessing economic investment required to scale up bariatri..:

Baker-Knight, James ; Pournaras, Dimitri J ; Mahawar, Kamal...
BMJ Open.  14 (2024)  7 - p. e084356 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Assessing the health and economic burden of obesity-related..:

Tatsuno, Ichiro ; Gerlier, Laetitia ; Olivieri, Anamaria-Vera..
BMJ Public Health.  2 (2024)  1 - p. e000302 , 2024
Link: https://doi.org/10.1136/..
 
?
3

Disutility of injectable therapies in obesity and type 2 di..:

McEwan, Phil ; Baker-Knight, James ; Ásbjörnsdóttir, Björg...
The European Journal of Health Economics.  24 (2022)  2 - p. 187-196 , 2022
Link: https://doi.org/10.1007/..
 
?
4

An Indirect Treatment Comparison of Semaglutide 2.0 mg vs D..:

Lingvay, Ildiko ; Bauer, Robert ; Baker-Knight, James..
The Journal of Clinical Endocrinology & Metabolism.  107 (2021)  5 - p. 1461-1469 , 2021
Link: https://doi.org/10.1210/..
 
?
5

Evaluating the Cost-Effectiveness of Once-Weekly Semaglutid..:

Capehorn, Matthew ; Hallén, Nino ; Baker-Knight, James..
Diabetes Therapy.  12 (2021)  2 - p. 537-555 , 2021
Link: https://doi.org/10.1007/..
 
?
6

Erratum to: The Economic Burden of Insulin-Related Hypoglyc..:

Parekh, Witesh ; Hoskins, Nicki ; Baker-Knight, James..
Diabetes Therapy.  8 (2017)  5 - p. 1195-1196 , 2017
Link: https://doi.org/10.1007/..
 
?
7

The Economic Burden of Insulin-Related Hypoglycemia in Spai:

Parekh, Witesh ; Hoskins, Nicki ; Baker-Knight, James..
Diabetes Therapy.  8 (2017)  4 - p. 899-913 , 2017
Link: https://doi.org/10.1007/..
 
?
8

Disutility of injectable therapies in obesity and type 2 di..:

McEwan, Phil ; Baker-Knight, James ; Ásbjörnsdóttir, Björg...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080344/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

The public economic burden of suboptimal type 2 diabetes co..:

Kotsopoulos, Nikolaos ; Connolly, Mark P ; Willis, Michael...
https://research.rug.nl/en/publications/640dd427-d006-4300-a452-e978ce5d0fd9.  , 2022
Link: https://hdl.handle.net/1..
 
?
10

An Indirect Treatment Comparison of Semaglutide 2.0 mg vs D..:

Lingvay, Ildiko ; Bauer, Robert ; Baker-Knight, James..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016460/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Evaluating the Cost-Effectiveness of Once-Weekly Semaglutid..:

Capehorn, Matthew ; Hallén, Nino ; Baker-Knight, James..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846640/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

The Economic Burden of Insulin-Related Hypoglycemia in Adul..:

Parekh, Witesh ; Streeton, Sophie E ; Baker-Knight, James...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984921/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
13

Erratum to: The Economic Burden of Insulin-Related Hypoglyc..:

Parekh, Witesh ; Hoskins, Nicki ; Baker-Knight, James..
1869-6953.  , 2017
Link: http://hdl.handle.net/10..
 
?
14

Erratum to: The Economic Burden of Insulin-Related Hypoglyc..:

Parekh, Witesh ; Hoskins, Nicki ; Baker-Knight, James..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630550/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
15

The Economic Burden of Insulin-Related Hypoglycemia in Spai:

Parekh, Witesh ; Hoskins, Nicki ; Baker-Knight, James..
1869-6953.  , 2017
Link: http://hdl.handle.net/10..
 
1-15